Independent Quality Control for B1 & B2

Why a second source of evidence matters

A manufacturer certificate is an essential part of a batch documentation package. Independent testing adds another source of analytical evidence, giving buyers a basis for reviewing reported results beyond the manufacturer's own summary. For this B1 and B2 inventory, the published independent results are identified as Sigma QC. Their value depends on the scope of the actual reports, the sample references and the methods used. Independence does not mean that every possible attribute has been tested or that the buyer's entire specification has been verified. Request the source reports so QA can understand what was measured and what remains outside the reported scope.

Read each Sigma assay against its batch

The reported B1 Sigma assay is 99.3% for batch Y02202501042. The B2 Sigma results are 98.88% for lot 2025052801 and 99.65% for lot 2025052901. These are three separate measurements associated with three defined inventory records. Keep the lot references beside the results in any supplier comparison or purchasing file. Do not present the highest value as an assay for all inventory, or average the values into a product-level claim. If purchasing changes the proposed lot allocation, QA should confirm that its review still covers the material being offered and the documentation accompanying that supply.

Compare sources without inventing conclusions

The B1 manufacturer assay is published as 99.5%, and the B2 manufacturer assay for lot 2025052801 as 99.3%. The manufacturer result for B2 lot 2025052901 is to be reviewed on its COA. Differences between manufacturer and independent figures need context: method, reporting basis, sample identity and applicable acceptance criteria. The public summary is not enough to conclude that a difference is either acceptable or a failure. QA should request clarification where needed. A supplier comparison is strongest when it preserves the original results and documents its interpretation rather than silently replacing one source with another.

Check scope, sample linkage and missing attributes

An independent assay is evidence for the tested attribute, not a substitute for identity, moisture, impurities or other controls your specification may require. Review the report's product and sample identifiers and confirm how they relate to the offered lot. Ask which tests were performed and where the methods and result basis are documented. If your receiving process requires additional testing or a retained sample, include that in the qualification discussion. Do not claim a complete independent test panel merely because an assay has been published. Treat a missing public detail as an open review question until the source package answers it.

Use QC evidence in the purchase decision

The practical next step is to request manufacturer certificates and independent Sigma documentation for the exact lot or lots under consideration. Supply your company, intended application, kilogram requirement and purchasing specification so the review is directed to a real commercial need. Your QA team can then record acceptance criteria, document versions, questions and any conditions of approval. If a sample is required, request it separately rather than assuming document review fulfills that step. The inventory's South Carolina location allows a domestic logistics discussion to proceed alongside diligence. Final release for purchase and use still rests with the buyer's QA, regulatory and supplier-approval processes.

Document the interpretation, not only the percentage

When the independent report arrives, record the questions it answers and the attributes it does not cover. A result may support the buyer's assay review while leaving other specification checks to the manufacturer COA or additional evaluation. Make those boundaries visible in your internal summary. If a comparison depends on method equivalence or a particular reporting basis, document the information used to reach that conclusion. Do not create an implied assurance that the independent laboratory has verified every supplier statement. The report is most useful when its scope is preserved and its relationship to the offered lot can be understood by the next reviewer.

Procurement can support QA by keeping requests precise and avoiding promotional interpretations of analytical data. Ask for the report associated with the proposed batch, retain the source label and use the value exactly as reported. If the commercial allocation changes, check whether the available independent evidence changes too. For a purchase covering both B2 lots, keep both Sigma results in the review record rather than selecting one representative percentage. Independent QC is a trust differentiator because it adds reviewable evidence, not because it creates an unsupported superiority claim. Your final decision should combine that evidence with the complete documentation and the specific acceptance conditions your organization requires.